Multifaceted roles of PD‐1 in tumorigenesis: From immune checkpoint to tumor cell‐intrinsic function

Abstract

Programmed cell death 1 (PD‐1), a key immune checkpoint receptor, has been extensively studied for its role in regulating immune responses in cancer. However, recent research has unveiled a complex and dual role for PD‐1 in tumorigenesis. While PD‐1 is traditionally associated with immune cells, this article explores its expression in various cancer cells and its impact on cancer progression. PD‐1's functions extend beyond immune regulation, as it has been found to both promote and suppress tumor growth, depending on the cancer type. These findings have significant implications for the future of cancer treatment and our understanding of the immune response in the context of cancer. This article calls for further research into the multifaceted roles of PD‐1 to optimize its therapeutic potential and improve patient outcomes in the fight against cancer.